New Snake Bite Treatment Targeted For 2028 US Release
O4X is developing Varespladib, a potential treatment for snake bite toxins. Dr. Platts-Mills stated the company aims to submit the drug to the FDA by late next year. If approved, the medication could be available in the United States by 2028.
Topics
Developing
- 890d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 890d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 890d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 890d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
KNX Los Angeles
“We think that we are in a position to submit to the FDA by late next year, hopefully making it available in 2028 in the U.S.”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade